Background: Total lung capacity (TLC) measured with single-breath gas diffusion (TLCsb) is systematically lower than TLC measured with whole-body plethysmography (TLCwbp) especially in patients with obstructive defects. We aimed to develop and validate a regression correction equation to reduce the discrepancy between the two measurements of TLC. Second, we compared the ability to detect restriction (reduced TLC) from adjusted TLC measured by single-breath (TLCsb) with gold standard TLCwbp.
Methods: Lung function data from 800 consecutive patients were analysed with multivariable linear regression. A group of 530 were included for model development, and 270 were used for model validation.
Results: TLCsb was found to be on average 1.1 L lower than TLCwbp ( < 0.001). This difference increased with degree of airway obstruction. After adjustment TLCsb did not significantly differ from TLCwbp in obstructive and mixed obstructive-restrictive subjects. TLCsb had a sensitivity of 70% and a specificity of 99% to predict restriction on an individual basis, with a 95% confidence interval (CI) of [-19.6%; 17.7%] percentage when comparing adjusted values of TLCsb with the true TLCwbp value.
Conclusions: After adjustment TLCsb was no longer significantly underestimated in obstructive and mixed restrictive-obstructive groups compared to TLCwbp. The adjustment can be used on individual subjects to estimate restriction via the TLCsb, thereby making the single-breath gas diffusion method a more valid alternative than without adjustment, when compared with the gold standard whole-body plethysmography to measure TLC.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11873942 | PMC |
http://dx.doi.org/10.1080/20018525.2025.2470002 | DOI Listing |
Am J Respir Crit Care Med
March 2025
University of Iowa, Radiology and Biomedical Engineering, Iowa City, Iowa, United States;
Rationale: Quantifying functional small airways disease (fSAD) requires additional expiratory computed tomography (CT) scan, limiting clinical applicability. Artificial intelligence (AI) could enable fSAD quantification from chest CT scan at total lung capacity (TLC) alone (fSAD).
Objectives: To evaluate an AI model for estimating fSAD, compare it with dual-volume parametric response mapping fSAD (fSAD), and assess its clinical associations and repeatability in chronic obstructive pulmonary disease (COPD).
Int J Chron Obstruct Pulmon Dis
March 2025
Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden, Lund University, Lund, Sweden.
Background: Severe alpha-1-antitrypsin deficiency (AATD) is a known risk factor for early development of emphysema and COPD. By the Swedish national screening program within the years 1972-74 a cohort of individuals with severe AATD (PiZZ) was identified and regularly followed up. The aim of this study was to investigate alveolar volume (V) and the ratio V/Total lung capacity (V/TLC) for the detection of signs of hyperinflation and ventilation heterogeneity in PiZZ individuals compared with an age-matched control group (phenotype PiMM), randomly selected from the population registry.
View Article and Find Full Text PDFTuberc Respir Dis (Seoul)
March 2025
Pulmonology Department, Sechenov First Moscow State Medical University (Sechenov University), Healthcare Ministry of Russia, 5, Dovator St.15, Bldg. 2, 119048, Moscow, Russia.
Background: Incorrect inhalation technique is one of the most common reasons for the ineffectiveness of Chronic Obstructive Pulmonary Disease (COPD) therapy, increasing the frequency of exacerbations. Selection of treatment based on Peak Inspiratory Flow (PIF) measurements or predictors of suboptimal PIF (sPIF) could optimize therapy in patients with COPD. The goal of this study was to investigate a prevalence and predictors of sPIF in hospitalized patients with acute exacerbation of COPD in clinical practice.
View Article and Find Full Text PDFJ Autoimmun
March 2025
Service de Médecine Interne, Centre de Référence Maladies Autoimmunes Systémiques Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; APHP-CUP, Hôpital Cochin, F-75014 Paris, Université Paris Cité, Paris.
Background: Total lung capacity (TLC) is seldom assessed in the prediction of systemic sclerosis (SSc) disease severity.
Objective: To describe and analyse TLC in SSc.
Methods: We performed a retrospective multicentre study of SSc patients enrolled in the French national SSc cohort with at least one TLC assessment, described patients based on baseline TLC measurements, modelized TLC trajectories in SSc, and associated TLC measures with disease prognosis.
Eur Clin Respir J
March 2025
Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Background: Total lung capacity (TLC) measured with single-breath gas diffusion (TLCsb) is systematically lower than TLC measured with whole-body plethysmography (TLCwbp) especially in patients with obstructive defects. We aimed to develop and validate a regression correction equation to reduce the discrepancy between the two measurements of TLC. Second, we compared the ability to detect restriction (reduced TLC) from adjusted TLC measured by single-breath (TLCsb) with gold standard TLCwbp.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!